Van Berkom & Associates’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-442,830
Closed -$46.4M 65
2025
Q2
$46.4M Sell
442,830
-207,231
-32% -$19.6M 1.38% 40
2025
Q1
$57.4M Sell
650,061
-188,260
-22% -$19.3M 1.84% 31
2024
Q4
$80.4M Sell
838,321
-97,260
-10% -$9.06M 2.39% 20
2024
Q3
$76.6M Buy
935,581
+5,413
+0.6% +$418K 2.1% 30
2024
Q2
$80.2M Buy
930,168
+16,807
+2% +$1.36M 2.4% 18
2024
Q1
$74.6M Sell
913,361
-67,990
-7% -$5.31M 2.12% 31
2023
Q4
$65.1M Sell
981,351
-61,119
-6% -$4.24M 1.89% 35
2023
Q3
$76.2M Buy
1,042,470
+51,824
+5% +$3.5M 2.48% 14
2023
Q2
$62.5M Sell
990,646
-47,731
-5% -$2.77M 2.27% 22
2023
Q1
$61M Buy
1,038,377
+280,461
+37% +$17M 2.25% 19
2022
Q4
$46.7M Buy
757,916
+38,001
+5% +$2.55M 2% 27
2022
Q3
$48.4M Sell
719,915
-17,862
-2% -$1.13M 2.3% 21
2022
Q2
$45.3M Sell
737,777
-148,331
-17% -$9.5M 1.9% 31
2022
Q1
$59.8M Buy
+886,108
New +$47.9M 2.14% 25

Other funds holding HQY

Van Berkom & Associates's HQY Position: Q3 2025 in Review

Van Berkom & Associates sold out of HealthEquity (HQY) in Q3 2025, closing a stake of 442,830 shares — an estimated $46.4M sold.

Van Berkom & Associates first reported a position in HQY in Q1 2022 and held it in 14 quarters. The position peaked at $80.4M in Q4 2024. 493 funds tracked by Wall St. Rank hold HQY as of Q3 2025.

  • Van Berkom & Associates reported no remaining HealthEquity position as of Q3 2025 after selling out during the quarter.
  • Van Berkom & Associates sold 442,830 HealthEquity shares in Q3 2025, an estimated $46.4M.
  • Van Berkom & Associates first reported a position in HealthEquity in Q1 2022 and held it in 14 quarters.
  • Van Berkom & Associates's HealthEquity position peaked at $80.4M in Q4 2024.
  • 493 funds tracked by Wall St. Rank held HealthEquity as of Q3 2025.

Based on Van Berkom & Associates's 13F filing for Q3 2025, filed 4 Nov 2025.